Cargando…
Involvement of adiponectin in the pathogenesis of dystrophinopathy
BACKGROUND: The hormone adiponectin (ApN) is decreased in the metabolic syndrome, where it plays a key pathogenic role. ApN also exerts some anti-inflammatory effects on skeletal muscles in mice exposed to acute or chronic inflammation. Here, we investigate whether ApN could be sufficiently potent t...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528853/ https://www.ncbi.nlm.nih.gov/pubmed/26257862 http://dx.doi.org/10.1186/s13395-015-0051-9 |
_version_ | 1782384715671535616 |
---|---|
author | Abou-Samra, Michel Lecompte, Sophie Schakman, Olivier Noel, Laurence Many, Marie C. Gailly, Philippe Brichard, Sonia M. |
author_facet | Abou-Samra, Michel Lecompte, Sophie Schakman, Olivier Noel, Laurence Many, Marie C. Gailly, Philippe Brichard, Sonia M. |
author_sort | Abou-Samra, Michel |
collection | PubMed |
description | BACKGROUND: The hormone adiponectin (ApN) is decreased in the metabolic syndrome, where it plays a key pathogenic role. ApN also exerts some anti-inflammatory effects on skeletal muscles in mice exposed to acute or chronic inflammation. Here, we investigate whether ApN could be sufficiently potent to counteract a severe degenerative muscle disease, with an inflammatory component such as Duchenne muscular dystrophy (DMD). METHODS: Mdx mice (a DMD model caused by dystrophin mutation) were crossed with mice overexpressing ApN in order to generate mdx-ApN mice; only littermates were used. Different markers of inflammation/oxidative stress and components of signaling pathways were studied. Global force was assessed by in vivo functional tests, and muscle injury with Evans Blue Dye (EBD). Eventually, primary cultures of human myotubes were used. RESULTS: Circulating ApN was markedly diminished in mdx mice. Replenishment of ApN strikingly reduced muscle inflammation, oxidative stress, and enhanced the expression of myogenic differentiation markers along with that of utrophin A (a dystrophin analog) in mdx-ApN mice. Accordingly, mdx-ApN mice exhibited higher global force and endurance as well as decreased muscle damage as quantified by curtailed extravasation of EBD in myofibers. These beneficial effects of ApN were recapitulated in human myotubes. ApN mediates its protection via the adiponectin receptor 1 (AdipoR1, the main ApN receptor in muscle) and the AMPK-SIRT1-PGC-1α signaling pathway, leading to downregulation of the nuclear factor kappa B (NF-κB) and inflammatory genes, together with upregulation of utrophin. CONCLUSIONS: Adiponectin proves to be an extremely powerful hormone capable of protecting the skeletal muscle against inflammation and injury, thereby offering novel therapeutic perspectives for dystrophinopathies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13395-015-0051-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4528853 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45288532015-08-08 Involvement of adiponectin in the pathogenesis of dystrophinopathy Abou-Samra, Michel Lecompte, Sophie Schakman, Olivier Noel, Laurence Many, Marie C. Gailly, Philippe Brichard, Sonia M. Skelet Muscle Research BACKGROUND: The hormone adiponectin (ApN) is decreased in the metabolic syndrome, where it plays a key pathogenic role. ApN also exerts some anti-inflammatory effects on skeletal muscles in mice exposed to acute or chronic inflammation. Here, we investigate whether ApN could be sufficiently potent to counteract a severe degenerative muscle disease, with an inflammatory component such as Duchenne muscular dystrophy (DMD). METHODS: Mdx mice (a DMD model caused by dystrophin mutation) were crossed with mice overexpressing ApN in order to generate mdx-ApN mice; only littermates were used. Different markers of inflammation/oxidative stress and components of signaling pathways were studied. Global force was assessed by in vivo functional tests, and muscle injury with Evans Blue Dye (EBD). Eventually, primary cultures of human myotubes were used. RESULTS: Circulating ApN was markedly diminished in mdx mice. Replenishment of ApN strikingly reduced muscle inflammation, oxidative stress, and enhanced the expression of myogenic differentiation markers along with that of utrophin A (a dystrophin analog) in mdx-ApN mice. Accordingly, mdx-ApN mice exhibited higher global force and endurance as well as decreased muscle damage as quantified by curtailed extravasation of EBD in myofibers. These beneficial effects of ApN were recapitulated in human myotubes. ApN mediates its protection via the adiponectin receptor 1 (AdipoR1, the main ApN receptor in muscle) and the AMPK-SIRT1-PGC-1α signaling pathway, leading to downregulation of the nuclear factor kappa B (NF-κB) and inflammatory genes, together with upregulation of utrophin. CONCLUSIONS: Adiponectin proves to be an extremely powerful hormone capable of protecting the skeletal muscle against inflammation and injury, thereby offering novel therapeutic perspectives for dystrophinopathies. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13395-015-0051-9) contains supplementary material, which is available to authorized users. BioMed Central 2015-08-07 /pmc/articles/PMC4528853/ /pubmed/26257862 http://dx.doi.org/10.1186/s13395-015-0051-9 Text en © Abou-Samra et al. 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Abou-Samra, Michel Lecompte, Sophie Schakman, Olivier Noel, Laurence Many, Marie C. Gailly, Philippe Brichard, Sonia M. Involvement of adiponectin in the pathogenesis of dystrophinopathy |
title | Involvement of adiponectin in the pathogenesis of dystrophinopathy |
title_full | Involvement of adiponectin in the pathogenesis of dystrophinopathy |
title_fullStr | Involvement of adiponectin in the pathogenesis of dystrophinopathy |
title_full_unstemmed | Involvement of adiponectin in the pathogenesis of dystrophinopathy |
title_short | Involvement of adiponectin in the pathogenesis of dystrophinopathy |
title_sort | involvement of adiponectin in the pathogenesis of dystrophinopathy |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528853/ https://www.ncbi.nlm.nih.gov/pubmed/26257862 http://dx.doi.org/10.1186/s13395-015-0051-9 |
work_keys_str_mv | AT abousamramichel involvementofadiponectininthepathogenesisofdystrophinopathy AT lecomptesophie involvementofadiponectininthepathogenesisofdystrophinopathy AT schakmanolivier involvementofadiponectininthepathogenesisofdystrophinopathy AT noellaurence involvementofadiponectininthepathogenesisofdystrophinopathy AT manymariec involvementofadiponectininthepathogenesisofdystrophinopathy AT gaillyphilippe involvementofadiponectininthepathogenesisofdystrophinopathy AT brichardsoniam involvementofadiponectininthepathogenesisofdystrophinopathy |